40 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Stealth BioTherapeutics, Inc. MITO shares surged 74.2% to $3.31 during Tuesday's pre-market session. According to the most recent rating by H.C. Wainwright, on December 23, the current rating is at Neutral.
• KemPharm, Inc. KMPH shares increased by 56.0% to $0.51.
• GenMark Diagnostics, Inc. GNMK shares rose 33.3% to $4.68. The most recent rating by Needham, on March 03, is at Buy, with a price target of $11.00.
• Ocugen, Inc. OCGN shares rose 25.5% to $0.60. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
• Qiagen, Inc. QGEN stock surged 16.0% to $41.91. The most recent rating by CFRA, on February 06, is at Hold, with a price target of $38.00.
• ADMA Biologics, Inc. ADMA shares increased by 13.8% to $3.38.
• Beyond Air, Inc. XAIR stock moved upwards by 10.9% to $10.40.
• Phio Pharmaceuticals, Inc. PHIO stock moved upwards by 9.1% to $3.37.
• Zosano Pharma, Inc. ZSAN shares rose 7.1% to $1.06.
• VBI Vaccines, Inc. VBIV stock moved upwards by 6.9% to $1.39.
• CannTrust Holdings, Inc. CTST shares increased by 6.3% to $0.70.
• Antares Pharma, Inc. ATRS stock increased by 5.9% to $3.41.
• Verastem, Inc. VSTM stock surged 5.7% to $3.15. The most recent rating by Cantor Fitzgerald, on March 03, is at Overweight, with a price target of $6.00.
• Achieve Life Sciences, Inc. ACHV stock moved upwards by 5.5% to $0.56. The most recent rating by H.C. Wainwright, on February 25, is at Buy, with a price target of $2.00.
• Thermo Fisher Scientific, Inc. TMO shares surged 3.5% to $315.51. The most recent rating by BTIG, on January 31, is at Buy, with a price target of $372.00.

Losers

• Spherix, Inc. SPEX shares fell 22.4% to $0.95 during Tuesday's pre-market session.
• Co-Diagnostics, Inc. CODX shares fell 15.9% to $14.97. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
• InflaRx, Inc. IFRX stock decreased by 15.3% to $5.15.
• Ritter Pharmaceuticals, Inc. RTTR shares decreased by 15.2% to $0.52.
• Tilray, Inc. TLRY stock fell 15.1% to $13.03. According to the most recent rating by Eight Capital, on March 03, the current rating is at Neutral.
• Vir Biotechnology, Inc. VIR shares fell 14.4% to $38.52. The most recent rating by JP Morgan, on February 04, is at Neutral, with a price target of $26.00.
• Allied Healthcare Prods, Inc. AHPI shares fell 13.7% to $13.50.
• Bionano Genomics, Inc. BNGO stock plummeted 13.6% to $1.08.
• Vaxart, Inc. VXRT shares decreased by 11.5% to $2.07.
• Dynatronics, Inc. DYNT shares fell 10.3% to $1.56.
• Trinity Biotech, Inc. TRIB shares fell 10.0% to $1.17.
• Novavax, Inc. NVAX shares fell 10.0% to $10.82. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
• Cocrystal Pharma, Inc. COCP shares decreased by 9.5% to $1.24.
• Pluristem Therapeutics, Inc. PSTI shares plummeted 8.8% to $3.61. The most recent rating by Dawson James, on December 16, is at Buy, with a price target of $12.00.
• Guardion Health Sciences, Inc. GHSI stock decreased by 8.7% to $0.45.
• Cleveland BioLabs, Inc. CBLI stock decreased by 8.6% to $2.65.
• Lianluo Smart, Inc. LLIT stock declined 8.4% to $0.75.
• Intec Pharma, Inc. NTEC stock fell 7.7% to $0.36.
• Titan Pharmaceuticals, Inc. TTNP stock fell 7.3% to $0.38.
• Cronos Group, Inc. CRON stock plummeted 7.3% to $5.58.
• BOQI International, Inc. BIMI shares plummeted 7.0% to $4.65.
• Moderna, Inc. MRNA stock declined 7.0% to $27.80. The most recent rating by Needham, on February 26, is at Buy, with a price target of $35.00.
• OpGen, Inc. OPGN stock plummeted 6.7% to $3.18.
• Tonix Pharmaceuticals, Inc. TNXP shares fell 6.6% to $1.27.
• Correvio Pharma, Inc. CORV stock declined 6.5% to $0.40. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.